OliverFreudenreichMD
Psychiatry • Boston, MAPsychosomatic Medicine, Clinical Pharmacology
Co-Director of the Massachusetts General Hospital Schizophrenia Clinical and Research Program. Director of the MGH Fellowship in Public and Community Psychiatry. Associate Professor of Psychiatry at Harvard Medical School.
Dr. Freudenreich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Department of Psychiatry
Boston, MA 02114Phone+1 617-912-7800Fax+1 617-723-3919- Is this information wrong?
Summary
- Dr. Oliver Freudenreich is an Associate Professor of Psychiatry at Harvard Medical School and a Psychiatrist at Massachusetts General Hospital (MGH). He serves as Co-Director of the MGH Schizophrenia Clinical and Research Program and directs the MGH Fellowship in Public and Community Psychiatry.
His academic interest is in the area of optimal psychopharmacological treatment for schizophrenia, including clozapine for refractory psychosis, the role of medical morbidity in schizophrenia, the integration of medicine and psychiatry, and treatment adherence. In addition to his clinical and clinical trial expertise in schizophrenia, Dr. Freudenreich provides psychiatric consultations for medically complex patients with serious mental illness or diagnostically difficult cases with psychosis. He is a deputy editor for the journal Psychosomatics. He has published extensively in his areas of interest and he wrote a handbook on psychotic disorders; a second edition was published in 2020. Dr. Freudenreich is an active teacher who lectures regularly at national meetings and at his home institution. At MGH, he was for many years the course director for the Department of Psychiatry’s monthly Morbidity and Mortality conference and Grand Rounds.
Education & Training
Rutgers Robert Wood Johnson Medical SchoolResidency, Psychiatry, 1995 - 1999
Ruprecht Karl University Faculty of MedicineClass of 1994
Certifications & Licensure
ME State Medical License 2020 - 2025
MA State Medical License 1999 - 2025- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Psychosomatic Medicine
Clinical Trials
- Risperidone Augmentation in Patients With Schizophrenia Start of enrollment: 2003 Feb 01
- Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study Start of enrollment: 2006 Jan 01
- Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Adult-Onset Stuttering in Schizophrenia With Catatonia That Responded to Electroconvulsive Therapy.Carol Lim, Smita Patel, Oliver Freudenreich> ;Journal of the Academy of Consultation-Liaison Psychiatry. 2023 Jul 20
- Determining Clinical Follow-Up in the Context of Widening LAI Intervals: How Long Is Too Long?Samuel J Dotson, Robert O Cotes, Oliver Freudenreich> ;The Journal of Clinical Psychiatry. 2023 May 31
- Mobile Vaccine Clinics for Patients With Serious Mental Illness and Health Care Workers in Outpatient Mental Health Clinics.Manjola U Van Alphen, Carol Lim, Oliver Freudenreich> ;Psychiatric Services. 2023 Sep 1
- Join now to see all
Other
- Guidelines for prescribing clozapine in schizophreniaFreudenreich O, McEvoy J
http://www.uptodate.com/contents/guidelines-for-prescribing-clozapine-in-schizophrenia
UpToDate, Wolters Kluwer Health - 2012-07-26
Press Mentions
Karuna’s Experimental Schizophrenia Drug Succeeds in Advanced StudyAugust 8th, 2022
Classification of Schizoaffective Disorder: The History of a Vexing ConceptMay 6th, 2020- Suicide in Schizophrenia Spectrum DisordersApril 6th, 2020
- Join now to see all
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
